• April 17, 2021
    • Loading stock data...
  • Research establishes antibiotic potential for cannabis molecule


    The main nonpsychoactive component of cannabis has been shown to kill Gram-negative bacteria for the first time.

    Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease.

    The research collaboration between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years.

    The UQ Institute for Molecular Bioscience‘s Associate Professor Mark Blaskovich said CBD – the main nonpsychoactive component of cannabis – can penetrate and kill a wide range of bacteria including Neisseria gonorrhoeae, which causes gonorrhoea.

    “This is the first time CBD has been shown to kill some types of Gram-negative bacteria. These bacteria have an extra outer membrane, an additional line of defence that makes it harder for antibiotics to penetrate,” Dr Blaskovich said.

    Read full article here: https://www.eurekalert.org/pub_releases/2021-01/uoq-rea011821.php?mc_cid=4ea618631e&mc_eid=b20cd943c2



    About Author

    Comments are closed.